Skip to main content

Table 3 Characteristics of included studies cont’d: phase of infection and funding source

From: Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review

Author Last Test Name Phase of infection Funding source
Boisen et al Recombinant Lassa Virus Rapid Diagnostic Test (ReLASV RDT) Acute phase NIH (National Institute for Health). Possible conflict of interest with Viral Hemorrrhagic fever Consortium.
Boisen et al Recombinant Lassa Virus Antigen ELISA (ReLASV Ag ELISA) NIH (National Institute for Health). Possible conflict of interest with Viral Hemorrrhagic fever Consortium.
Bausch et al Combined ELISA Antigen/IgM assay Acute phase. Convalescent samples collected but data on testing not given. American Association of Schools of Public Health (AASPH) & Tulane University
Indirect Immunofluorescent antibody test
Gabriel et al IgM ELISA Not clear European Fund for regional development
IgM/IgG ELISA
Ibekwe et al IgM ELISA Acute phase No funding source
Meulen et al. IgM/IgG Immunoblot Not clear Not stated
Emmerich et al Reverse IgG ELISA Convalescent samples (from survivors) Bundesamt f¨ur Wehrtechnik und Beschaffung
Olschlager et al GPC RT-PCR(Qiagen) Not clear Bundesamt f¨ur Wehrtechnik und Beschaffung
Trappier et al Conventional PCR Not clear Not stated